Predicted Values Of Mean Qtcf And Associated Two Sided 90 Cis

Predicted values of mean QTcF and associated two-sided 90% CIs ...
Predicted values of mean QTcF and associated two-sided 90% CIs ...
Predicted values of mean QTcF and associated two-sided 90% CIs ...
Predicted values of mean QTcF and associated two-sided 90% CIs ...
Mean change from baseline in QTcF (a) and QTcB (b). Mean values are ...
Mean change from baseline in QTcF (a) and QTcB (b). Mean values are ...
Mean change from baseline in QTcF (a) and QTcB (b). Mean values are ...
Mean change from baseline in QTcF (a) and QTcB (b). Mean values are ...
Mean QTcF and QRS Values Across Methodologies and Randomization Status ...
Mean QTcF and QRS Values Across Methodologies and Randomization Status ...
(a) Mean QTcF values and (b) mean HR values as calculated by the BRAVO ...
(a) Mean QTcF values and (b) mean HR values as calculated by the BRAVO ...
Placebo-adjusted moxifloxacin QtcF cFB means and 90% cis by time-point ...
Placebo-adjusted moxifloxacin QtcF cFB means and 90% cis by time-point ...
Mean (2-sided 90 % CI) QTcF change from baseline by venetoclax dose ...
Mean (2-sided 90 % CI) QTcF change from baseline by venetoclax dose ...
Compound 2. (A) QTcF across dose groups and time points Mean with 90%CI ...
Compound 2. (A) QTcF across dose groups and time points Mean with 90%CI ...
Compound 2. (A) QTcF across dose groups and time points Mean with 90%CI ...
Compound 2. (A) QTcF across dose groups and time points Mean with 90%CI ...
Scatterplot of individual QTcF values versus CAB concentrations with ...
Scatterplot of individual QTcF values versus CAB concentrations with ...
QTcF prolongation and shortening may both be associated with marked ...
QTcF prolongation and shortening may both be associated with marked ...
Least squares mean and upper bound (UB) of two-sided 90% confidence ...
Least squares mean and upper bound (UB) of two-sided 90% confidence ...
Mean change in QTcF from baseline by visit and allocated treatment arm ...
Mean change in QTcF from baseline by visit and allocated treatment arm ...
Compound 2. (A) QTcF across dose groups and time points Mean with 90%CI ...
Compound 2. (A) QTcF across dose groups and time points Mean with 90%CI ...
Compound 2. (A) QTcF across dose groups and time points Mean with 90%CI ...
Compound 2. (A) QTcF across dose groups and time points Mean with 90%CI ...
Mean Changes From Time-Matched Baseline in QTcI and QTcF | Download ...
Mean Changes From Time-Matched Baseline in QTcI and QTcF | Download ...
Scatterplots of T-wave roundness versus QTcF values on beat-to-beat ...
Scatterplots of T-wave roundness versus QTcF values on beat-to-beat ...
Concordance between the predicted and measured QTc values in sample B ...
Concordance between the predicted and measured QTc values in sample B ...
Simulated QTcF (a baseline, b with drug) and ΔQTcF values for three ...
Simulated QTcF (a baseline, b with drug) and ΔQTcF values for three ...
Mean QTcF by visit and allocated treatment arm. | Download Scientific ...
Mean QTcF by visit and allocated treatment arm. | Download Scientific ...
Simulated QTcF (a baseline, b with drug) and ΔQTcF values for three ...
Simulated QTcF (a baseline, b with drug) and ΔQTcF values for three ...
Scatterplot of individual QTcF values versus CAB concentrations with ...
Scatterplot of individual QTcF values versus CAB concentrations with ...
Change in mean QTcF interval by month of treatment. 1 | Download ...
Change in mean QTcF interval by month of treatment. 1 | Download ...
Least-squares mean difference and 90% CI of ΔΔQTcF. Abbreviation: CI ...
Least-squares mean difference and 90% CI of ΔΔQTcF. Abbreviation: CI ...
Mean differences between predose QTcF intervals at baseline and at 4-h ...
Mean differences between predose QTcF intervals at baseline and at 4-h ...
Compound 2. (A) QTcF across dose groups and time points Mean with 90%CI ...
Compound 2. (A) QTcF across dose groups and time points Mean with 90%CI ...
Figure ∆∆QTcF and associated 90%two-sided confidence intervals after ...
Figure ∆∆QTcF and associated 90%two-sided confidence intervals after ...
Exposure–response model predictions of mean ∆QTcF versus concentration ...
Exposure–response model predictions of mean ∆QTcF versus concentration ...
LS mean change ± 2-sided 90% CI from baseline in QTcF (ΔQTcF) with ...
LS mean change ± 2-sided 90% CI from baseline in QTcF (ΔQTcF) with ...
LS mean change ± 2-sided 90% CI from baseline in QTcF (ΔQTcF) with ...
LS mean change ± 2-sided 90% CI from baseline in QTcF (ΔQTcF) with ...
Model-predicted QTcF (mean and 90%CI) and estimated placebo-adjusted ...
Model-predicted QTcF (mean and 90%CI) and estimated placebo-adjusted ...
Model‐predicted corrected change from baseline for QTcF (ΔΔQTcF; mean ...
Model‐predicted corrected change from baseline for QTcF (ΔΔQTcF; mean ...
Mean maximum predicted ∆QTcF with time-matched nivolumab serum ...
Mean maximum predicted ∆QTcF with time-matched nivolumab serum ...
Placebo-corrected changes in QTcF for macimorelin and moxifloxacin ...
Placebo-corrected changes in QTcF for macimorelin and moxifloxacin ...
QTcF (Fridericia's correction) adjusted mean (90% CI) change from ...
QTcF (Fridericia's correction) adjusted mean (90% CI) change from ...

Loading image details...

Source
Dimensions